BPS Program Book 2014

Name

Disclosure Entity

Disclosure Type

Presentation Number

Doerr, Leo

Nanion Technologies Genentech, Inc. eDAQ Pty Ltd DNASTAR, Inc. Oxford Nanopore Oxford Nanopore

Employment (full or part-time) in funding company 3702-Pos Employment (full or part-time) in funding company 2810-Pos Employment (full or part-time) in funding company 1500-Pos Employment (full or part-time) in funding company 1044-Pos

Dourado, Michelle Duckworth, Paul Edlunde, Erik G.

Eggenberger, Olivia M. Eggenberger, Olivia

Research funded by industry grant Research funded by industry grant

1081-Pos 1080-Pos

Ehring, George R. El-Bizri, Nesrine

Allergan, Inc

Employment (full or part-time) in funding company 1650-Pos Employment (full or part-time) in funding company 1664-Pos Employment (full or part-time) in funding company 3267-Plat Employment (full or part-time) in funding company 2228-Plat Employment (full or part-time) in funding company 1757-Pos Employment (full or part-time) in funding company 3070-Pos

Gilead Sciences GlaxoSmithKline

Ellis, James L. Engelke, Frank Fan, Peidong

Bruker

Gilead Inc.

Farid, Ramy

Schrodinger, Inc. Gilead Science Inc.

Fenaux, Martijn

Stock options or bond holdings in a for-profit corporation or self-directed pension plan

1330-Pos

Ferguson, Kathryn M.

Imclone Systems

Research funded by industry grant Research funded by industry grant

557-Pos 1757-Pos

Ferrantini, Cecilia

Gilead Inc.

Fertig, Niels Fertig, Niels Fertig, Niels

Nanion Technologies Nanion Technologies Nanion Technologies

Ownership or Partnership in funding organization 680-Pos Ownership or Partnership in funding organization 3702-Pos Ownership or Partnership in funding organization 694-Pos Employment (full or part-time) in funding company 3601-Pos Employment (full or part-time) in funding company 3861-Pos Employment (full or part-time) in funding company 736-Pos Employment (full or part-time) in funding company 2137-Symp Consulting fees or other remuneration from industry 3585-Pos Employment (full or part-time) in funding company 996-Pos Ownership or Partnership in funding organization 680-Pos Employment (full or part-time) in funding company 3702-Pos Ownership or Partnership in funding organization 694-Pos Employment (full or part-time) in funding company 3692-Pos Ownership or Partnership in funding organization 2659-Pos Employment (full or part-time) in funding company 694-Pos Employment (full or part-time) in funding company 2020-Pos Employment (full or part-time) in funding company 736-Pos Employment (full or part-time) in funding company 1419-Pos Employment (full or part-time) in funding company 3702-Pos Employment (full or part-time) in funding company 694-Pos Employment (full or part-time) in funding company 4033-Pos Employment (full or part-time) in funding company 680-Pos Employment (full or part-time) in funding company 694-Pos Employment (full or part-time) in funding company 2810-Pos Research funded by industry grant 2582-Pos Research funded by industry grant 1650-Pos Other 1554-Pos Research funded by industry grant 2227-Plat

Feuston, Bradley P.

Merck Research Laboratories

Friis, Soren

Sophion Bioscience

Gaither, Larry A.

Novartis

Galla Hans, Joachim Bitop AG

Gardner, Timothy Garry, Robert F.

Amyris

Autoimmune Technologies

Gayda, Susan

Abbott

George, Michael George, Michael George, Michael George, Alfred L.

Nanion Technologies Nanion Technologies Nanion Technologies

Allergan

Ghermazien, Haben T.

MyoKardia Inc

Gillis, Kevin D.

ExoCytronics LLC

Goepel, Sven

AstraZeneca

Goldstein, Goldie Gosling, Martin Griffis, Joshua W. Guimarães, Paola B.

4D Technology Corp

Novartis

PathoGenetix

FAPESP

Guinot, David Guinot, David

Nanion Technologies Nanion Technologies

Guo, Senli

Bruker Corp

Guy, Andrew T.

Oxford Nanopore Technologies

Haarmann, Claudia Haarmann, Claudia Hackos, David H.

Nanion Technologies Nanion Technologies

Genentech, Inc.

292

Biophysical Society 58 th Annual Meeting, San Francisco, California